The cytokine network in asthma and chronic obstructive pulmonary disease
Top Cited Papers
- 3 November 2008
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 118 (11), 3546-3556
- https://doi.org/10.1172/jci36130
Abstract
Asthma and chronic obstructive pulmonary disease (COPD) are very common inflammatory diseases of the airways. They both cause airway narrowing and are increasing in incidence throughout the world, imposing enormous burdens on health care. Cytokines play a key role in orchestrating the chronic inflammation and structural changes of the respiratory tract in both asthma and COPD and have become important targets for the development of new therapeutic strategies in these diseases.This publication has 131 references indexed in Scilit:
- The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγtNature Immunology, 2008
- Immunology of asthma and chronic obstructive pulmonary diseaseNature Reviews Immunology, 2008
- In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammationJournal of Clinical Investigation, 2007
- IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC–activated Th2 memory cellsThe Journal of Experimental Medicine, 2007
- Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cellsThe Journal of Experimental Medicine, 2007
- IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivoProceedings of the National Academy of Sciences, 2007
- Inhibitory effect of p38 mitogen‐activated protein kinase inhibitors on cytokine release from human macrophagesBritish Journal of Pharmacology, 2006
- How corticosteroids control inflammation: Quintiles Prize Lecture 2005British Journal of Pharmacology, 2006
- Phosphodiesterase inhibitors in airways diseaseEuropean Journal of Pharmacology, 2006
- An Immune Basis for Lung Parenchymal Destruction in Chronic Obstructive Pulmonary Disease and EmphysemaPLoS Medicine, 2004